Abstract:Delivery of antigens by injection of the encoding DNA allows access to multiple antigen-presenting pathways. Knowledge of immunological processes can therefore be used to modify construct design to induce selected effector functions. Expression can be directed to specific intracellular sites, and additional genes can be fused or codelivered to amplify responses. Therapeutic vaccination against cancer adds a requirement to overcome tolerance and to activate a weakened immune repertoire. Induction of CD4(+) T helper cells is critical for both antibody and T cell effector responses. To activate immunity against tumor antigens, we fused the tumor-derived sequences to genes encoding microbial proteins. This strategy engages T helper cells from the large antimicrobial repertoire for linked help for inducing antibody against cell-surface tumor antigens. The principle of linked T cell help also holds for induction of epitope-specific antitumor CD8(+) T cells, but the microbial sequence has to be minimized to avoid competition with tumor antigens. Epitope-specific DNA vaccination leads to powerful antitumor attack and can activate immunity from a profoundly tolerized repertoire. Vaccine designs validated in preclinical models are now in clinical trial with immune responses detected against both tumor antigens and fused microbial antigens. DNA priming is highly efficient, but boosting may benefit from increased antigen expression. Physical methods including electroporation provide increased expression without introducing additional competing antigens. A wide range of cancers can be targeted, and objective assays of response will determine efficacy.

[Mechanism of Priming Cytotoxic T Cell Response and Strategy for Enhancing DNA Vaccine Potency in DNA Immunization].

Progress for Improving the Immune Response of DNA Vaccine

Increasing a robust antigen-specific cytotoxic T lymphocyte response by FMDV DNA vaccination with IL-9 expressing construct.

Immunomechanism and Optimized Strategies of DNA Vaccines

Dna is an Efficient Booster of Dendritic Cell-Based Vaccine

Immunostimulatory Bacterial Dna Sequences Activate Dendritic Cells And Promote Priming And Differentiation Of Cd8(+) T Cells

Enhanced Immunostimulatory Activity of a Cytosine-Phosphate-Guanosine Immunomodulator by the Assembly of Polymer DNA Wires and Spheres

DNA vaccines to attack cancer

Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity

New insights for the development of efficient DNA vaccines

DNA Vaccination: Transfection and Activation of Dendritic Cells As Key Events for Immunity.

Sequential Administration of Cytokine Genes to Enhance Cellular Immune Responses and Cd4(+) T Memory Cells During Dna Vaccination

Combinations of Various CpG Motifs Cloned into Plasmid Backbone Modulate and Enhance Protective Immunity of Viral Replicon DNA Anthrax Vaccines

Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly.

Induction of antigen-positive cell death by the expression of perforin, but not DTa, from a DNA vaccine enhances the immune response

Engineering of in Vivo Immune Responses to DNA Immunization Via Codelivery of Costimulatory Molecule Genes.

DNA Vaccine Delivery and Improved Immunogenicity.

Enhanced Efficacy of DNA Vaccination Against Botulinum Neurotoxin Serotype A by Co-Administration of Plasmids Encoding DC-stimulating Flt3L and MIP-3α Cytokines.

Peptide-TLR7/8a-Coordinated DNA Vaccines Elicit Enhanced Immune Responses against Infectious Diseases

Successive Site Translocating Inoculation Potentiates DNA/recombinant Vaccinia Vaccination

Dendritic Cells Targeting and Ph-Responsive Multi-layered Nanocomplexes for Smart Delivery of DNA Vaccines